Whole-genome sequencing of Asian lung cancers: Second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers

Cancer Research

Volumn 74, Issue 21, 2014, Pages 6071-6081

  Krishnan, Vidhya G ^a   Ebert, Philip J ^b   Ting, Jason C ^b   Lim, Elaine ^c,d,e   Wong, Swee Seong ^b   Teo, Audrey S M ^a   Yue, Yong G ^b   Chua, Hui Hoon ^a   Ma, Xiwen ^b   Loh, Gary S L ^a   Lin, Yuhao ^b   Tan, Joanna H J ^a   Yu, Kun ^b   Zhang, Shenli ^f   Reinhard, Christoph ^b   Tan, Daniel S W ^g   Peters, Brock A ^h   Lincoln, Stephen E ^h   Ballinger, Dennis G ^h   Laramie, Jason M ^h   Nilsen, Geoffrey B ^h   Barber, Thomas D ^b   Tan, Patrick ^a,f,g,i   Hillmer, Axel M ^a   Ng, Pauline C ^a   more..

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b ELI LILLY AND COMPANY   (United States)

^c MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^h Complete Genomics Inc ^*  (United States)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; EGFR PROTEIN, HUMAN; PASSIVE SMOKING; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASIAN; BIOINFORMATICS; CANCER INCIDENCE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EGFR GENE; EUROPEAN; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INDEL MUTATION; MALE; MUTATIONAL ANALYSIS; NEVER SMOKER; NON SMALL CELL LUNG CANCER; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; PASSIVE SMOKING; PATIENT CODING; PHENOTYPE; POINT MUTATION; POPULATION GROUP; SOMATIC MUTATION; SOMATIC SINGLE NUCLEOTIDE VARIANT; TUMOR SUPPRESSOR GENE; VERY ELDERLY; WHOLE GENOME SEQUENCING; ASIAN CONTINENTAL ANCESTRY GROUP; DNA DAMAGE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; PATHOLOGY; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; DNA DAMAGE; FEMALE; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; TOBACCO SMOKE POLLUTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84909592557     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3195     Document Type: Article

References (42)

1. Xiong D, Li G, Li K, Xu Q, Pan Z, Ding F, et al. Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. Carcinogenesis 2012;33:1797-805.
2. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011;331:1553-8.
3. Hainaut P, Pfeifer GP. Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001;22:367-74.
4. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010;465:473-7.
5. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010;463:191-6.
6. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010;463:184-90.
7. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-75.
8. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-66.
9. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012;149:979-93.
10. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, et al. The life history of 21 breast cancers. Cell 2012;149:994-1007.
11. Zhao Y, Wang S, Aunan K, Seip HM, Hao J. Air pollution and lung cancer risks in China - a meta-analysis. Sci Total Environ 2006;366: 500-13.
12. Zhong L, Goldberg MS, Gao YT, Jin F. Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. Epidemiology 1999;10:488-94.
13. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012;150:1121-34.
14. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012;150:1107-20.
15. Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 2012;22: 2315-27.
16. Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, et al. Identification of somatic mutations in non-small cell lung carcinomas using wholeexome sequencing. Carcinogenesis 2012;33:1270-6.
17. Liu ZM, Liu LN, Li M, Zhang QP, Cheng SH, Lu S. Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer. Oncol Rep 2009;22:515-20.
18. Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006;118:257-62.
19. Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 2008;5:e185.
20. Grimmer G, Naujack KW, Dettbarn G. Gaschromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes. Toxicol Lett 1987;35:117-24.
21. Chuang JC, Mack GA, Kuhlman MR, Wilson NK. Polycyclic aromatic hydrocarbons and their derivatives in indoor and outdoor air in an eight-home study. Atmospheric Environ 1991;25B:369-80.
22. Vu-Duc T, Huynh C-K. Sidestream tobacco smoke constituents in indoor air modelled in an experimental chamber - polycyclic aromatic hydrocarbons. Environ Int 1989;15:57-64.
23. Brunnemann KD, Yu L, Hoffmann D. Assessment of carcinogenic volatile N-nitrosamines in tobacco and in mainstream and sidestream smoke from cigarettes. Cancer Res 1977;37:3218-22.
24. Martin P, Heavner DL, Nelson PR, Maiolo KC, Risner CH, Simmons PS, et al. Environmental tobacco smoke (ETS): a market cigarette study. Environ Int 1997;23:75-90.
25. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010;327: 78-81.
26. Seo JS, Ju YS, Lee WC, Shin JY, Lee JK, Bleazard T, et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012;22:2109-19.
27. Haney JC, Hanna JM, Berry MF, Harpole DH, D'Amico TA, Tong BC, et al. Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. J Thorac Cardiovasc Surg 2014;147:1164-8.
28. Kawanishi S, Hiraku Y, Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 2001;488:65-76.
29. Pastoriza Gallego M, Sarasin A. Transcription-coupled repair of 8-oxoguanine in human cells and its deficiency in some DNA repair diseases. Biochimie 2003;85:1073-82.
30. Broet P, Dalmasso C, Tan EH, Alifano M, Zhang S,WuJ, et al. Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res 2011;17:3542-50.
31. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-46.
32. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
33. Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 2008;14: 5731-4.
34. Li M, Liu L, Liu Z, Yue S, Zhou L, Zhang Q, et al. The status of KRAS mutations in patients with non-small cell lung cancers from mainland China. Oncol Rep 2009;22:1013-20.
35. Wu CC, Hsu HY, Liu HP, Chang JW, Chen YT, Hsieh WY, et al. Reversed mutation rates ofKRASand EGFRgenes in adenocarcinoma of the lung in Taiwan and their implications. Cancer 2008;113:3199-208.
36. Anastas JN, Moon RT.WNTsignalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013;13:11-26.
37. Whang YM, Jo U, Sung JS, Ju HJ, Kim HK, Park KH, et al. Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C. PLoS ONE 2013;8:e53012.
38. Lai CH, Jaakkola JJ, Chuang CY, Liou SH, Lung SC, Loh CH, et al. Exposure to cooking oil fumes and oxidative damages: a longitudinal study in Chinese military cooks. J Expo Sci Environ Epidemiol 2013;23:94-100.
39. Fry JS, Lee PN, Forey BA, Coombs KJ. How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model. Regul Toxicol Pharmacol 2013;67:13-26.
40. Choi YL, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, et al. EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. PLoS ONE 2013;8:e56011.
41. Lynch JA, Khoury MJ, Borzecki A, Cromwell J, Hayman LL, Ponte PR, et al. Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. GenetMed 2013;15:630-8.
42. Jain A, Koo SL, Chan KS, Ng QS, Chau NM, Ang MK, et al. Influence of smoking status on response to EGFR TKI - a retrospective analysis of reflex EGFR mutation testing in Asian patients with advanced lung adenocarcinomas. Ann Oncol 2012;23: Supplement 9, 1257P.